The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S. Federal Trade Commission said Tuesday.[#item_full_content]

Germania, 1.700 miliardi in dieci anni. Svolta sul debito: Berlino si riarma
Read More 2 minuti di lettura Supplementi Repubblica Gedi News Network La Stampa HuffPost Italia Fem Formula Passion Quotidiani locali La Provincia Pavese La Sentinella